AC-NP: A novel chimeric peptide with natriuretic and vasorelaxing actions

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Chen, Bao Ying ^a,b   Chen, Jian Kang ^b   Zhu, Miao Zhang ^b   Zhang, Dong Liang ^b   Sun, Jie Shen ^b   Pei, Jian Ming ^b   Feng, Hua Song ^c   Zhu, Xiao Xing ^b   Jin, Jian ^d   Yu, Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c General Hospital of Navy   (China)

^d JIANGNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AC NP PEPTIDE; ATRIAL NATRIURETIC FACTOR; CHIMERIC PROTEIN; CYCLIC GMP; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG; VASONATRIN PEPTIDE; HYBRID PROTEIN;

ABDOMINAL AORTA; AMINO ACID BLOOD LEVEL; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; MALE; NONHUMAN; NUCLEIC ACID STRUCTURE; NUCLEOTIDE METABOLISM; RAT; STRUCTURE ANALYSIS; URINARY EXCRETION; VASODILATATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; HEART; HUMAN; KIDNEY; MOLECULAR GENETICS; NATRIURESIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

AMINO ACID SEQUENCE; ANIMALS; AORTA, ABDOMINAL; ATRIAL NATRIURETIC FACTOR; HEART; HUMANS; KIDNEY; MALE; MOLECULAR SEQUENCE DATA; NATRIURESIS; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; VASODILATION;

EID: 79956352799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020477     Document Type: Article

References (15)

1. Boerrigter G, Costello-Boerrigter LC, Burnett JC Jr, (2009) Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin 5: 501-514.
2. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM, (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191: 341-366.
3. Duda T, (2010) Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism. Mol Cell Biochem 334: 37-51.
4. Clavell AL, Stingo AJ, Wei CM, Heublein DM, Burnett JC Jr, (1993) C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol 264: R290-R295.
5. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG, (1994) Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 78: 1428-1435.
6. La Villa G, Mannelli M, Lazzeri C, Vecchiarino S, de Feo ML, et al. (1998) Different effects of atrial and C-type natriuretic peptide on the urinary excretion of endothelin-1 in man. Clin Sci (Lond) 95: 595-602.
7. Igaki T, Itoh H, Suga SI, Hama N, Ogawa Y, et al. (1998) Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens Res 21: 7-13.
8. Foran SE, Carr DB, Lipkowski AW, Maszczynska I, Marchand JE, et al. (2000) A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic. Proc Natl Acad Sci U S A 97: 7621-7626.
9. Wei CM, Kim CH, Miller VM, Burnett JC Jr, (1993) Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 92: 2048-2052.
10. Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC Jr, (2008) Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52: 60-68.
11. Kilic A, Rajapurohitam V, Sandberg SM, Zeidan A, Hunter JC, et al. (2010) A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway. Cardiovasc Res 88: 434-442.
12. Yandle TG, (1994) Biochemistry of natriuretic peptides. J Intern Med 235: 561-576.
13. Warshaw DM, Mulvany MJ, Halpern W, (1979) Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats. Circ Res 45: 250-259.
14. Chen BY, Qu P, Tie R, Zhu MZ, Zhu XX, et al. (2010) Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis. Regul Pept 164: 139-143.
15. Woodard GE, Li X, Brown J, Rosado JA, (2005) Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries. Regul Pept 129: 183-189.